Uncategorized – Prognica Labs

Khalid Shaikh got awarded with UAE Golden Visa for his contribution in Artificial Intelligence, Medical Science & Public Health

April 24, 2022
No Comments

Dubai, UAE, 21 Mar, 2022: Khalid Shaikh, Founder CEO of Prognica Labs, and a visionary in the field of artificial intelligence, medical sciences and research, was recently awarded the UAE Golden Visa.

“I am honored to have received the Golden Visa. This marks a milestone in my life. Rewards and appreciation like these are what keeps me motivated, extremely glad and elated for this massive token of recognition.”

We are also partnering with hospitals and universities. With such partnerships, we conduct seminars, cohorts and idea competitions for students, as well as help young researchers in identifying the characteristics of the economic environment.

Khalid Shaikh said “I was delighted to hear that I was selected for the Golden Visa. UAE aims to develop a knowledge-based economy where people of high talent and innovation are pivotal for its success. Hence, granting golden visa is a testament of my dedication, contribution, and commitment to UAE’s success.”

Prognica Labs won Etisalat SMB Awards 2021 as Best Artificial Intelligence Company

February 17, 2022
No Comments

Dubai, UAE, 17 Feb, 2022: Prognica Labs, an AI powered health tech company wins the Etisalat SMB awards 2021, in Artificial intelligence category . The company received outstanding scores across several aspects of their endeavors such as improving the clinical outcomes in the fight against breast cancer , and giving back to the community by emphasizing on preventative health and wellbeing. This year’s Awards recognized 10 categories, namely Emirati Business, Women in Business, Digital Transformation, Artificial Intelligence, Top Sustainability, Business Mobility, Top Healthcare, CSR, Tech for Good, and SMB of the Year.

Esam Mahmoud, Senior Vice President, SMB, Etisalat, said, “Small and medium businesses today make up for about 98 per cent of businesses in the UAE representing over 60 per cent of the country’s GDP, therefore an important segment in Etisalat’s business. This is an integral component to our overall business and is driven by a commitment to the future of UAE.

In a statement from Khalid Shaikh, Founder & CEO of Prognica Labs, “It’s a great feeling to be recognized for your efforts, passion and perseverance!!!
At Prognica Labs, we are happy to receive Etisalat SMB Award by Etisalat UAE in a category of “Artificial Intelligence”.

“We are delighted to receive this award in Artificial intelligence category, which is testament of the commitment and dedication on working towards our vision. This recognition is the greatest motivator” said Dr Sreelekshmi Bekal, Medical Director.

About Prognica Labs :

Prognica Labs is a Dubai based AI powered health-tech startup aiming to improve clinical outcomes in the fight against breast cancer. Prognica analyses medical images and generates information and data to help predict and diagnose cancer using artificial intelligence and deep learning. They are tackling a long term goal by working on breast cancer screening and diagnostics to make it more accurate, affordable and accessible. At Prognica Labs , they meticulously work towards research that generates new knowledge to drive effective innovation, education, practice, and can help policy, which will benefit students, professors, professionals and general public. For more information, please visit http://www.prognica.com/

About Etisalat :

Emirates Telecommunication Group Company PJSC, doing business as Etisalat, is a Emirati-based multinational telecommunications services provider, currently operating in 16 countries across Asia, the Middle East and Africa. It is the 18th largest mobile network operator in the world by number of subscribers.
The Etisalat SMB Awards 2021 is a recognition platform that honours prominent businesses that have demonstrated powerful leadership & influenced the region’s business landscape. This initiative recognizes the essential role played by small and medium businesses in transforming and supporting the growth of the country’s economy. For more information, please visit https://www.etisalat.ae/en/smb/events/awards/awards2021.jsp

Dr. Menna Shaher Joins Prognica Labs’ Advisory Board

December 18, 2020
No Comments

Dubai, UAE — Dec 16, 2020 — Prognica Labs, a Dubai based AI-powered health-tech startup aiming to improve clinical outcomes in the fight against breast cancer using artificial intelligence and deep learning; today announced that Dr. Menna Shaher has joined as an Advisor.

Dr. Menna has over 15 years of experience as a Breast Radiologist, 11 years of which as a Consultant Breast Imaging and Intervention Radiology.

Her areas of expertise include Breast Mammography, early detection of breast cancer, Tomosynthesis, Contrast-Enhanced mammography and Dynamic MRI breast with contrast, Breast and axilla ultrasound with Elastography, Breast interventional studies as biopsy and aspiration & Total suction of benign lesions by vacuum assist Biopsy (VAB).

Dr. Menna completed MBBS, Masters in Radio diagnosis & Intervention and Medical Doctorate in Diagnostic Radiology from Ain Shams University, Cairo, Egypt, and Advanced Hospital Management Diploma from Canadian International Academy for advanced studies, Ottawa, Canada. She is a member of the European Society of Breast Imaging. She is also the founder and head of the Breast Unit of Al Zahra Hospital Sharjah.

“With her vast experience and passion in breast cancer space, along with the combination of strategic expertise, it will be of a tremendous resource in helping Prognica accelerate its vision in serving the society,” said Khalid Shaikh, Founder CEO at Prognica.

“I’m honored to be working with the Prognica team as they are tackling a long-term goal by working on breast cancer screening and diagnostics to make it more accurate, affordable, and accessible.” Dr. Menna said. “I believe in networking, joining forces that can make miracles, and I admire the hard work and ideas Prognica is trying to implement. Looking forward to doing more together.”

Prognica Labs Joins NVIDIA Inception

December 6, 2020
No Comments

Dubai, UAE — Dec 09, 2020 — Prognica Labs today announced it has joined NVIDIA Inception, a program designed to nurture startups revolutionizing industries with advancements in AI and data sciences.

Breast cancer is the most commonly diagnosed cancer in women (24.2%, i.e. about one in 4 of all new cancer cases diagnosed in women worldwide are breast cancer). Approximately 2.1 million women were diagnosed with breast cancer in 2018, according to a WHO report. In developing countries, more than 50% of the women who are detected with breast cancer end up losing their lives within a year.

Examining medical images and data is time-consuming and relies on the judgment and skills of highly specialized experts and many a time the interpretation is prone to errors since humans suffer from factors like fatigue and distractions. This is why patients sometimes have different interpretations from various doctors, which can make choosing a plan of action a stressful and tedious process.

Prognica is addressing these issues through our AI-powered platform, which can analyze medical images and generate medical reports — from anywhere and with complete accuracy.

NVIDIA Inception will allow Prognica to better collaborate with many other cutting-edge Artificial Intelligence and machine learning startups by leveraging valuable go-to-market support, expertise, and technology. Joining this program will help and support Prognica Labs’ Computer Vision and Machine Learning solutions. The program will also offer Prognica the opportunity to collaborate with industry-leading experts and other AI-driven organizations.

Khalid Shaikh, CEO, Founder of Prognica Labs said – “Prevention and early detection are central to our mission of helping save lives, celebrate lives, and lead the fight against cancer. We are developing an adjunct, precision tool for mammography and ultrasound to equip radiologists with the objective, data-driven results they need to support patients and their healthcare team as they make decisions about their breast cancer screening, treatment, and diagnosis. We expect our participation in NVIDIA’s Inception program to push the limits of innovation with AI-based medical diagnosis to greater heights to serve the global society.”

NVIDIA Inception is a program that helps startups during critical stages of product development, prototyping, and deployment. Every Inception member gets a custom set of ongoing benefits, such as NVIDIA Deep Learning Institute credits, marketing support, and technical assistance, which provides startups with the fundamental tools to help them grow.

About Prognica Labs
Prognica Labs is a Dubai based AI-powered health-tech startup aiming to improve clinical outcomes in the fight against breast cancer. Prognica analyses medical images and generates information and data to help predict and diagnose cancer using artificial intelligence and deep learning. We are tackling a long-term goal by working on breast cancer screening and diagnostics to make it more accurate, affordable, and accessible.

Contact:
Prognica Labs
Khalid Shaikh (Founder, CEO)
khalid@prognica.com